Raconteur Global Resources Limited has secured in-principle approval from BSE Limited for a preferential issue of equity shares and warrants, marking a significant corporate development for the Mumbai-based company. The approval was communicated through BSE's letter dated March 4, 2026, and subsequently announced by the company on March 5, 2026.

Details of the Preferential Issue

The BSE approval encompasses three distinct components of the preferential issue, all priced at a minimum of Rs. 14/- per share:

The warrants are convertible into an equal number of equity shares, providing flexibility for the allottees. Additionally, the loan conversion component involves converting existing loans aggregating to Rs. 6,18,00,000/- into equity shares.

Regulatory Compliance Requirements

BSE has outlined comprehensive compliance requirements that Raconteur Global Resources must adhere to during the issuance process. The exchange has emphasized that this in-principle approval should not be construed as automatic listing approval, requiring separate compliance for listing procedures.

Key compliance areas include:

• Adherence to Companies Act, 2013
• Securities Contracts (Regulation) Act, 1956
• SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
• SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Depositories Act, 1996

Trading Restrictions and Internal Controls

The exchange has mandated specific measures to prevent non-compliance with trading regulations. The company must obtain undertakings from allottees confirming they will not engage in intra-day trading or any sales in the company's scrip until the allotment date.

BSE has placed the responsibility solely on Raconteur Global Resources to verify compliance with these provisions, including Regulation 167(6) of SEBI ICDR Regulations, 2018. Any non-compliance observed post-undertaking may impact the listing of the issued shares.

Timeline and Post-Issue Formalities

Following the allotment of securities, the company must submit a listing application within twenty days, as specified in Schedule XIX – Para (2) of ICDR Regulations and SEBI circular dated June 21, 2023. Non-compliance with this timeline will attract penalties as outlined in the regulatory framework.

The exchange has reserved the right to withdraw the in-principle approval if any information is found to be incomplete, incorrect, misleading, or in contravention of applicable regulations. This preferential issue represents a significant capital-raising initiative for Raconteur Global Resources, subject to successful completion of all regulatory requirements and compliance measures.

Raconteur Global Resources Limited successfully conducted its 2nd Extraordinary General Meeting on January 9, 2026, securing shareholder approval for three significant corporate resolutions. The meeting addressed key strategic decisions including board restructuring and capital raising initiatives through preferential allotments.

Director Appointment Approved

Shareholders approved the appointment of Ms. Gowhar Parveen Mallick (DIN: 11225598) as Non-Executive Non-Independent Director. The Board had initially appointed her as Additional Director on November 14, 2025, and the EGM formalized her change in designation to Non-Executive Non-Independent Director.

The company confirmed that Ms. Mallick is not debarred from holding directorship by any SEBI order or regulatory authority, and she has no relationships with existing directors.

Preferential Equity Share Allotment

The EGM approved preferential allotment of 8,428,565 equity shares to non-promoter public category shareholders at ₹14.00 per share, including ₹4.00 premium. The issue price was determined by a registered valuer in accordance with Regulation 164 of SEBI ICDR Regulations.

The allotment includes 13 investors, with Ecomatix Solutions Private Limited receiving the largest allocation of 3,700,000 shares, followed by Atharva Professional Consultants LLP with 2,142,857 shares. Individual investors include Maanya Somani (714,285 shares), Natures Heavens India Private Limited (714,285 shares), and Rakesh Kumar (357,142 shares).

Warrants Convertible into Equity Shares

Shareholders also approved issuance of 22,321,421 warrants convertible into equity shares on preferential basis to non-promoter public category shareholders. Each warrant is convertible into one equity share at ₹14.00 per share within 18 months from allotment date.

The warrant allotment spans 16 investors, with major allocations to Ankit Sapra, Indra Financial Services Limited, and Cosmos Investfi Asset Management LLP, each receiving 3,095,238 warrants. Regency Digitrade Investments Private Limited will receive 2,500,000 warrants, while Sampat Singh Ahluwalia and Max Bio Biosciences Private Limited are allocated 2,142,857 warrants each.

Regulatory Compliance and Terms

All approvals comply with Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The warrants include adjustment provisions for corporate actions such as bonus issues, rights issues, or share subdivisions during the conversion period. Warrant holders must pay the full conversion price before exercising conversion options, which can be done in one or more tranches within the specified timeframe.

The company has fulfilled all disclosure requirements under SEBI regulations and submitted detailed annexures containing investor-wise allocation details and compliance confirmations to BSE Limited.